Posts tagged: BioMarin

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Thursday, 21 July 2016, 9:46 pm

I see Bloomberg was today badgering Dr Severin Schwan, the Roche chief executive, into providing a denial to my BioMarin story from a few weeks ago.

According to the Bloomberg story I read today, Dr Schwan said Roche was looking at small to medium-sized acquistions although he believes biotech valuations are "too high" even after the recent market correction...

Read more...

Roche said to have rekindled interest in BioMarin Pharmaceutical - sources

Wednesday, 6 July 2016, 12:00 am

Swiss pharmaceuticals giant Roche has once again been studying a multi-billon dollar purchase of American rare disease specialist BioMarin Pharmaceutical, according to two sources familiar with the matter.

I understand that, so far, the majority of work and analysis on BioMarin has been carried out by Roche's own executives, led by Boris Zaitra, head of M&A...

Read more...

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin Pharmaceutical - sources

Friday, 17 June 2016, 12:00 am

French pharmaceutical giant Sanofi is working on a back up plan in case it fails to win its $9.3 billion hostile pursuit of US-listed Medivation.

Top sources have told me the French pharmaceutical giant has begun looking at US-based rare disease specialist BioMarin Pharmaceutical as a potential alternative takeover deal after growing frustrated in its pursuit of Medivation, which has so far resisted the French company's advances...

Read more...